These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8622113)
21. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Pfaller MA; Sader HS; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2006 Sep; 56(1):63-8. PubMed ID: 16650951 [TBL] [Abstract][Full Text] [Related]
22. Post-antibiotic effect of isepamicin compared to that of other aminoglycosides. Minguez F; Agra M; Lurueña S; Ramos C; Prieto J Drugs Exp Clin Res; 1990; 16(5):231-5. PubMed ID: 2078989 [TBL] [Abstract][Full Text] [Related]
23. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563 [TBL] [Abstract][Full Text] [Related]
24. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp]. Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan. Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729 [TBL] [Abstract][Full Text] [Related]
26. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China. Xiao Y; Hu Y Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755 [TBL] [Abstract][Full Text] [Related]
28. Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used. Busch-Sørensen C; Sönmezoglu M; Frimodt-Møller N; Højbjerg T; Miller GH; Espersen F APMIS; 1996 Oct; 104(10):763-8. PubMed ID: 8980628 [TBL] [Abstract][Full Text] [Related]
29. Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006). Rhomberg PR; Deshpande LM; Kirby JT; Jones RN Diagn Microbiol Infect Dis; 2007 Dec; 59(4):425-32. PubMed ID: 17662557 [TBL] [Abstract][Full Text] [Related]
30. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004). Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564 [TBL] [Abstract][Full Text] [Related]
31. Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp. Castanheira M; Jones RN; Livermore DM Diagn Microbiol Infect Dis; 2009 Apr; 63(4):426-33. PubMed ID: 19249180 [TBL] [Abstract][Full Text] [Related]
32. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Biedenbach DJ; Toleman M; Walsh TR; Jones RN Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025 [TBL] [Abstract][Full Text] [Related]
33. Invitro comparative evaluation of aminoglycosides at a cancer centre. Biswas SK; Kelkar RS Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571 [TBL] [Abstract][Full Text] [Related]
34. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Streit JM; Jones RN; Sader HS; Fritsche TR Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308 [TBL] [Abstract][Full Text] [Related]
35. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci. Jones RN; Johnson DM; Barrett MS; Erwin ME J Chemother; 1991 Oct; 3(5):289-94. PubMed ID: 1809808 [TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of resistance to dactimicin and isepamicin in clinical strains of gram-negative rods isolated in Czechoslovakia]. Kettner M; Miller GH; Inouye S Bratisl Lek Listy; 1992 Mar; 93(3):131-5. PubMed ID: 1525686 [TBL] [Abstract][Full Text] [Related]
38. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876 [TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro activity of isepamicin and other antibiotics against gram-negative bacilli from intensive care units (ICU) in Belgium. Belgian Isepamicin Multicenter Study Group Acta Clin Belg; 2001; 56(5):307-15. PubMed ID: 11774843 [TBL] [Abstract][Full Text] [Related]